HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

4- (4- (5,6,7,8- tetrahydro- 5,5,8,8- tetramethyl- 2- quinoxalinyl)- 1,3- thiazol- 2- yl)benzoic acid

an RARgamma agonist; structure in first source

Also Known As:

ER 36009; ER-36009; ER36009

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Azoles: 2138
    - Thiazoles: 392
      - 4-(4-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-quinoxalinyl)-1,3-thiazol-2-yl)benzoic acid: 1
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Quinoxalines: 324
      - 4-(4-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-quinoxalinyl)-1,3-thiazol-2-yl)benzoic acid: 1
Organic Chemicals: 133
- Sulfur Compounds: 278
  - Thiazoles: 392
    - 4-(4-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-quinoxalinyl)-1,3-thiazol-2-yl)benzoic acid: 1

Experts

1.	Kanayama, Toshiji: 1 article (08/2006)
2.	Sakuta, Tomohiro: 1 article (08/2006)
3.	Uchiyama, Taro: 1 article (08/2006)

Related Diseases

1.	Obesity 08/01/2006 - "Topically applied ER36009 may have potential for the treatment of obesity."